{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:44:22Z","timestamp":1760060662289,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a well-established biomarker of cardiac stress and has recently been implicated in hematologic malignancies. However, research on how NT-proBNP changes from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM), and its association with disease severity and progression, remains limited. This study evaluated whether NT-proBNP levels are associated with disease severity and progression in patients with MGUS and MM. Methods: This retrospective cross-sectional study included 121 patients with MGUS and 472 patients with MM. MGUS risk was stratified based on the presence of three major risk factors, while MM was staged according to the ISS, R-ISS, and R2-ISS systems. Associations between NT-proBNP and clinical or laboratory parameters were evaluated using univariate and multivariate regression. Results: NT-proBNP levels did not significantly differ between the MGUS and MM groups. In MGUS, NT-proBNP levels were positively associated with \u03b22-microglobulin (p = 0.018) and creatinine (p &lt; 0.001). In MM, NT-proBNP levels increased with advancing disease stage in all staging systems (p &lt; 0.001), but these associations were no longer significant in multivariate models. Instead, \u03b22-microglobulin, LDH, creatinine, and albumin remained independently associated with NT-proBNP levels. Conclusions: NT-proBNP levels were not associated with MGUS risk factors and showed limited value for risk stratification in MGUS. In MM, NT-proBNP may reflect disease burden but lacks independent value as a marker of disease stage. NT-proBNP may serve as an indicator of overall disease burden, but has limited value as an independent biomarker for disease severity in MM.<\/jats:p>","DOI":"10.3390\/jcm14186381","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T12:04:55Z","timestamp":1757505895000},"page":"6381","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NT-proBNP as a Biomarker in MGUS and Multiple Myeloma: A Retrospective Analysis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6842-0234","authenticated-orcid":false,"given":"Jooheon","family":"Park","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Chonnam National University Hwasun Hospital, Hwasun 58128, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-5754","authenticated-orcid":false,"given":"Yong Jun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chonnam National University Hwasun Hospital, Hwasun 58128, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2436-5007","authenticated-orcid":false,"given":"Ha Jin","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chonnam National University Hospital, Gwangju 61469, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9342-0570","authenticated-orcid":false,"given":"Yong Jun","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chonnam National University Hospital, Gwangju 61469, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0372-9185","authenticated-orcid":false,"given":"Myung Geun","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chonnam National University Hwasun Hospital, Hwasun 58128, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0637-4364","authenticated-orcid":false,"given":"Eun-Hee","family":"Nah","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chonnam National University Hwasun Hospital, Hwasun 58128, Republic of Korea"},{"name":"Department of Laboratory Medicine, Chonnam National University Hospital, Gwangju 61469, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1161\/01.CIR.102.25.3074","article-title":"Gene Expression of Brain Natriuretic Peptide in Isolated Atrial and Ventricular Human Myocardium: Influence of Angiotensin II and Diastolic Fiber Length","volume":"102","author":"Wiese","year":"2000","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/eurheartj\/eht466","article-title":"Natriuretic Peptides in Cardiovascular Diseases: Current Use and Perspectives","volume":"35","author":"Volpe","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/heartjnl-2015-307848","article-title":"Cardiovascular Biomarkers in Patients with Cancer and Their Association with All-Cause Mortality","volume":"101","author":"Pavo","year":"2015","journal-title":"Heart"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1751-7133.2011.00258.x","article-title":"Exaggerated NT-proBNP Production in Patients with Hematologic Malignancies: A Case Series","volume":"18","author":"Andreu","year":"2012","journal-title":"Congest. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.coc.0000256101.04404.b0","article-title":"Cancer Patients with Markedly Elevated B-Type Natriuretic Peptide May Not Have Volume Overload","volume":"30","author":"Burjonroppa","year":"2007","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3892\/ol.2023.13866","article-title":"Levels of NT-proBNP in Patients with Cancer","volume":"26","author":"Chovanec","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ajh.24532","article-title":"N-terminal Fragment of the type-B Natriuretic Peptide (NT-proBNP) Contributes to a Simple New Frailty Score in Patients with Newly Diagnosed Multiple Myeloma","volume":"91","author":"Milani","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e12905","DOI":"10.1111\/eci.12905","article-title":"NT-proBNP Is Associated with Disease Severity in Multiple Myeloma","volume":"48","author":"Pavo","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood-2017-09-807560","article-title":"How I Manage Monoclonal Gammopathy of Undetermined Significance","volume":"131","author":"Go","year":"2018","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ajh.27545","article-title":"Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients with Intermediate\/High-Risk MGUS","volume":"100","author":"Mangiacavalli","year":"2025","journal-title":"Am. J. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.echo.2010.03.027","article-title":"Independent Predictors of Survival in Primary Systemic (Al) Amyloidosis, including cardiac biomarkers and left ventricular strain imaging: An observational cohort study","volume":"23","author":"Bellavia","year":"2010","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4065\/mcp.2010.0520","article-title":"Advances in the Diagnosis, Classification, Risk Stratification, and Management of Monoclonal Gammopathy of Undetermined Significance","volume":"85","author":"Rajkumar","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International Staging System for Multiple Myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for Multiple Myeloma","volume":"33","author":"Palumbo","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1200\/JCO.21.02614","article-title":"Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma","volume":"40","author":"Cairns","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Awada, H., Thapa, B., Awada, H., Dong, J., Gurnari, C., Hari, P., and Dhakal, B. (2021). A Comprehensive Review of the Genomics of Multiple Myeloma. Cells, 10.","DOI":"10.3390\/cells10081961"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101472","DOI":"10.1016\/j.tranon.2022.101472","article-title":"Correlation of Changes in Subclonal Architecture with Progression in the MMRF CoMMpass Study","volume":"23","author":"Kaur","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/leu.2013.199","article-title":"Intraclonal Heterogeneity Is a Critical Early Event in the Development of Myeloma","volume":"28","author":"Walker","year":"2013","journal-title":"Leukemia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple Myeloma: 2022 Update on Diagnosis, Risk Stratification, and Management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s44313-024-00001-1","article-title":"Genomic Technologies for Detecting Structural Variations in Hematologic Malignancies","volume":"59","author":"Jang","year":"2024","journal-title":"Blood Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1200\/JCO.1986.4.1.80","article-title":"Prognostic Factors and Staging in Multiple Myeloma: A Reappraisal","volume":"4","author":"Bataille","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1365-2141.1999.01635.x","article-title":"Increased Serum Levels of Beta2m-Free HLA Class I Heavy Chain in Multiple Myeloma","volume":"106","author":"Perosa","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.4049\/jimmunol.159.10.4781","article-title":"Beta 2-Microglobulin-Deficient Mice Are Protected from Hypergammaglobulinemia","volume":"159","author":"Christianson","year":"1997","journal-title":"J. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00467-022-05577-3","article-title":"Urine Alpha 1-Microglobulin-to-Creatinine Ratio and Beta 2-Microglobulin-to-Creatinine Ratio for Detecting CAKUT in Children","volume":"38","author":"Hamada","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/oemed-2021-107989","article-title":"Markers of Kidney Tubular and Interstitial Injury and Function among Sugarcane Workers with Cross-Harvest Serum Creatinine Elevation","volume":"79","author":"Hansson","year":"2022","journal-title":"Occup. Environ. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Tentolouris, A., Ntanasis-Stathopoulos, I., Gavriatopoulou, M., Andreadou, I., and Terpos, E. (2023). Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights. J. Cardiovasc. Dev. Dis., 10.","DOI":"10.3390\/jcdd10120484"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gkalea, V., Fotiou, D., Dimopoulos, M.A., and Kastritis, E. (2023). Monoclonal Gammopathy of Thrombotic Significance. Cancers, 15.","DOI":"10.3390\/cancers15020480"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaccao.2022.05.009","article-title":"Cardiovascular Morbidity in Monoclonal Gammopathy of Undetermined Significance: A Danish Nationwide Study","volume":"4","author":"Schwartz","year":"2022","journal-title":"JACC Cardio Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaccao.2022.07.002","article-title":"Cardiovascular Associations with Monoclonal Gammopathy of Undetermined Significance: Real or Coincidental?","volume":"4","author":"Kapoor","year":"2022","journal-title":"JACC Cardio Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1152\/japplphysiol.90442.2008","article-title":"Plasma NT-proBNP Increases in Response to LPS Administration in Healthy Men","volume":"105","author":"Vila","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00277-009-0841-4","article-title":"Serum Albumin Level Is a Significant Prognostic Factor Reflecting Disease Severity in Symptomatic Multiple Myeloma","volume":"89","author":"Kim","year":"2010","journal-title":"Ann. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.18632\/oncotarget.26647","article-title":"N-Terminal pro-Brain Natriuretic Peptide Reflects Both Left Ventricular Diastolic Dysfunction and Myeloma-Related Renal Insufficiency and Robustly Predicts Mortality in Patients with Symptomatic Multiple Myeloma","volume":"10","author":"Abe","year":"2019","journal-title":"Oncotarget"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6381\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:43:17Z","timestamp":1760035397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/18\/6381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":34,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["jcm14186381"],"URL":"https:\/\/doi.org\/10.3390\/jcm14186381","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,9,10]]}}}